MetaCap

Intellia Therapeutics Statistics

NASDAQ: NTLAHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD

10.00+0.48 (+5.04%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Intellia Therapeutics by the numbers

Intellia Therapeutics has a market capitalization of $1.40 billion based on 140.36M shares outstanding. With trailing EPS of $-3.35, Intellia Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 14.3% below its 50-day average and 22.4% below its 200-day average.

Average daily trading volume is 5.03M shares, or about $50.3 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

NTLA valuation vs. peer median

NTLA compared with the median of 8 peer companies
MetricNTLAPeer medianDifference
Market cap$1.40B$547.30M+156%
Avg. volume5.03M1.36M+271%

Peer median across 8 companies: CLDX, QUIT, QDEL, MYGN, NEOG, TKNO, NNNN, ICCC.

Valuation

Price / sales (latest FY)
20.74
EPS (TTM)
$-3.35

Price and trading

Previous close
9.52
Open
9.34
Day range
9.30 – 10.40
52-week range
8.09 – 18.48
52-week change
+21.80%
Beta
—
Volume
15.18M

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
1.40B
Forward Pe
-3.71
Eps
-3.35
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
18.48
Week52 Low
8.09
Avg Volume
5.03M
Shares Outstanding
140.36M
Ma50
11.67
Ma200
12.89
Earnings Date
Nov 5, 2026
Pct From52w High
-45.89%
Pct From52w Low
23.69%

Related